1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Kimberly-Clark

Anonymous board for Kimberly-Clark


Sort By:
Title
Replies ↓ Views
Last Message
  1. Anonymous
    Replies:
    298
    Views:
    41,927
  2. Anonymous
    Replies:
    171
    Views:
    47,797
  3. Anonymous
    Replies:
    67
    Views:
    21,737
  4. Anonymous
    Replies:
    64
    Views:
    35,003
  5. Anonymous
    Replies:
    64
    Views:
    9,920
  6. Anonymous
    Replies:
    52
    Views:
    9,265
  7. Anonymous
    Replies:
    48
    Views:
    6,257
  8. Anonymous
    Replies:
    43
    Views:
    10,329
  9. Anonymous
    Replies:
    39
    Views:
    7,603
  10. Anonymous
    Replies:
    36
    Views:
    21,316
  11. Anonymous
    Replies:
    33
    Views:
    11,790
  12. Anonymous
    Replies:
    29
    Views:
    6,329
  13. Anonymous
    Replies:
    29
    Views:
    11,240
  14. Anonymous
    Replies:
    26
    Views:
    7,043
  15. Anonymous
    Replies:
    26
    Views:
    4,534
  16. Anonymous
    Replies:
    25
    Views:
    14,241
  17. Anonymous
    Replies:
    23
    Views:
    6,566
  18. Anonymous
    Replies:
    23
    Views:
    2,981
  19. Anonymous
    Replies:
    22
    Views:
    3,401
  20. Anonymous
    Replies:
    21
    Views:
    7,095

Thread Display Options

Loading...